Radiology, Mayo Clinic, Rochester, Minnesota, USA
Radiology, Mayo Clinic, Rochester, Minnesota, USA.
J Neurointerv Surg. 2021 Apr;13(4):384-389. doi: 10.1136/neurintsurg-2020-015957. Epub 2020 Jun 2.
To assess if leukoaraiosis severity is associated with outcome in patients with acute ischemic stroke (AIS) following endovascular thrombectomy, and to propose a leukoaraiosis-related modification to the ASPECTS score.
A retrospective review was completed of AIS patients that underwent mechanical thrombectomy for anterior circulation large vessel occlusion. The primary outcome measure was 90-day mRS. A proposed Leukoaraiosis-ASPECTS ("L-ASPECTS") was calculated by subtracting from the traditional ASPECT based on leukoaraiosis severity (1 point subtracted if mild, 2 if moderate, 3 if severe). L-ASEPCTS score performance was validated using a consecutive cohort of 75 AIS LVO patients.
174 patients were included in this retrospective analysis: average age: 68.0±9.1. 28 (16.1%) had no leukoaraiosis, 66 (37.9%) had mild, 62 (35.6%) had moderate, and 18 (10.3%) had severe. Leukoaraiosis severity was associated with worse 90-day mRS among all patients (P=0.0005). Both L-ASPECTS and ASPECTS were associated with poor outcomes, but the area under the curve (AUC) was higher with L-ASPECTS (P<0.0001 and AUC=0.7 for L-ASPECTS; P=0.04 and AUC=0.59 for ASPECTS). In the validation cohort, the AUC for L-ASPECTS was 0.79 while the AUC for ASPECTS was 0.70. Of patients that had successful reperfusion (mTICI 2b/3), the AUC for traditional ASPECTS in predicting good functional outcome was 0.80: AUC for L-ASPECTS was 0.89.
Leukoaraiosis severity on pre-mechanical thrombectomy NCCT is associated with worse 90-day outcome in patients with AIS following endovascular recanalization, and is an independent risk factor for worse outcomes. A proposed L-ASPECTS score had stronger association with outcome than the traditional ASPECTS score.
评估急性缺血性卒中(AIS)患者血管内血栓切除术治疗后,脑白质疏松症严重程度与结局是否相关,并提出一种基于 ASPECTS 的脑白质疏松症相关改良评分。
对接受机械取栓治疗前循环大血管闭塞的 AIS 患者进行回顾性分析。主要结局指标为 90 天 mRS。根据脑白质疏松症严重程度(轻度 1 分,中度 2 分,重度 3 分),从传统 ASPECT 中减去得出拟议的脑白质疏松症-ASPECTS(“L-ASPECTS”)。使用连续的 75 例 AIS LVO 患者队列验证 L-ASEPCTS 评分的性能。
共纳入 174 例回顾性分析患者,平均年龄为 68.0±9.1 岁。28 例(16.1%)无脑白质疏松症,66 例(37.9%)为轻度,62 例(35.6%)为中度,18 例(10.3%)为重度。所有患者的脑白质疏松症严重程度与 90 天 mRS 较差有关(P=0.0005)。L-ASPECTS 和 ASPECTS 均与不良结局相关,但 L-ASPECTS 的曲线下面积(AUC)更高(P<0.0001,L-ASPECTS 的 AUC=0.7;P=0.04,ASPECTS 的 AUC=0.59)。在验证队列中,L-ASPECTS 的 AUC 为 0.79,ASPECTS 的 AUC 为 0.70。在成功再灌注(mTICI 2b/3)的患者中,传统 ASPECTS 预测良好功能结局的 AUC 为 0.80:L-ASPECTS 的 AUC 为 0.89。
血管内血栓切除术治疗前 NCCT 上的脑白质疏松症严重程度与血管内再通治疗后 AIS 患者 90 天结局较差相关,是结局较差的独立危险因素。提出的 L-ASPECTS 评分与结局的相关性强于传统 ASPECTS 评分。